Shelley B. Thunen, See remarks at RxSight, Inc. (RXST), sold 29,722 shares at $48.69 ($1.4M) on 2024-10-01, disclosed to the SEC on 2024-10-02.
Scheduled sale ($1.4M) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.96 | 5,201 | $249K | 17.3% |
| 2 | $47.96 | 5,201 | $249K | 17.3% |
| 3 | $48.69 | 9,521 | $464K | 32.2% |
| 4 | $48.69 | 9,521 | $464K | 32.2% |
| 5 | $49.45 | 278 | $14K | 1.0% |
| Total | $48.44 avg | 29,722 |
| $1.4M |
| 100% |
| Filing → |
| RXST | SELL | 2024-04-02 | $1.9M | — | Filing → |
| RXST | SELL | 2024-03-05 | $1.1M | — | Filing → |
| RXST | SELL | 2024-02-07 | $2.4M | — | Filing → |